Researchers at Beijing Tiantan Hospital have developed a one-stage hybrid approach that combines embolization and microsurgical removal of hypervascular central nervous system (CNS) tumors in a single operation. In a decade-long study of 31 patients, this innovative method reduced blood loss, avoided embolization-related complications, and preserved neurological function. Published in the Chinese Neurosurgical Journal, the findings suggest a safer alternative to traditional staged surgeries for treating high-risk brain and spinal tumors.

A new study published in the journal Nature Genetics maps out the timeline of DNA damage for multiple myeloma. The findings may lead to better ways to group patients by the state of their DNA and define new subtypes of disease to better predict treatment strategies and outcomes.

OKLAHOMA CITY – Large cell neuroendocrine carcinoma (LCNEC), a rare and aggressive type of lung cancer, has a high chance of metastasis, no standard treatment and a poor survival rate. A study published in Nature Communications provides a new understanding of the disease and uncovers a potential target for treatment.

Study finds cancer cells break down protective nerve coverings, leading to nerve injury and chronic inflammation

These nerve injuries drive immune exhaustion and immunotherapy resistance

Targeting the cancer-induced nerve injury pathway can reverse resistance and improve treatment response

Findings highlight importance of studying cancer neuroscience – the interactions between cancer and the nervous system